Resource and Cost Considerations in Treating Hypoplastic Left Heart Syndrome

Overview

Journal Pediatric Health Med Ther

Publisher Dove Medical Press

Date 2018 Feb 2

PMID 29388599

Citations 1

Authors

Miguel Urencio

Chris Greenleaf

Jorge D Salazar

Ali Dodge-Khatami

Affiliations

Soon will be listed here.

Abstract

Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, when surgical treatment was first undertaken with the Norwood I operation as the first of 3-staged operations. Since then, operative survival rate of stage I has risen from 53% to over 90% in the current era, not only thanks to technical advances in surgery but also through prenatal diagnosis and imaging, enhanced cardiopulmonary bypass technology, better perioperative intensive care, and closer interstage monitoring. The improvements in patient outcomes achieved through rigorous multidisciplinary teamwork have come at a tremendous cost in manpower and resources, making HLHS still a challenge to all congenital heart programs, established or emerging. We review the various surgical steps to treat HLHS and their current expected outcomes, and put into perspective cost considerations compared to other more "simple" congenital heart defects.

Citing Articles

Hypoplastic Left Heart Syndrome: A New Paradigm for an Old Disease?.

Grossfeld P, Nie S, Lin L, Wang L, Anderson R J Cardiovasc Dev Dis. 2019; 6(1).

PMID: 30813450 PMC: 6462956. DOI: 10.3390/jcdd6010010.

References

Gibbs J, Wren C, Watterson K, Hunter S, Hamilton J . Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome. Br Heart J. 1993; 69(6):551-5. PMC: 1025171. DOI: 10.1136/hrt.69.6.551. View

Schidlow D, Tworetzky W, Wilkins-Haug L . Percutaneous fetal cardiac interventions for structural heart disease. Am J Perinatol. 2014; 31(7):629-36. PMC: 4278657. DOI: 10.1055/s-0034-1383884. View

Checchia P, McCollegan J, Daher N, Kolovos N, Levy F, Markovitz B . The effect of surgical case volume on outcome after the Norwood procedure. J Thorac Cardiovasc Surg. 2005; 129(4):754-9. DOI: 10.1016/j.jtcvs.2004.07.056. View

Wilder T, McCrindle B, Phillips A, Blackstone E, Rajeswaran J, Williams W . Survival and right ventricular performance for matched children after stage-1 Norwood: Modified Blalock-Taussig shunt versus right-ventricle-to-pulmonary-artery conduit. J Thorac Cardiovasc Surg. 2015; 150(6):1440-50, 1452.e1-8. DOI: 10.1016/j.jtcvs.2015.06.069. View

Bernstein D, Naftel D, Chin C, Addonizio L, Gamberg P, Blume E . Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006; 114(4):273-80. DOI: 10.1161/CIRCULATIONAHA.105.548016. View

Eghtesady P, Brar A, Hall M . Seasonality of hypoplastic left heart syndrome in the United States: a 10-year time-series analysis. J Thorac Cardiovasc Surg. 2010; 141(2):432-8. DOI: 10.1016/j.jtcvs.2010.06.060. View

Norwood W, Lang P, Hansen D . Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med. 1983; 308(1):23-6. DOI: 10.1056/NEJM198301063080106. View

Faraoni D, Nasr V, DiNardo J . Overall Hospital Cost Estimates in Children with Congenital Heart Disease: Analysis of the 2012 Kid's Inpatient Database. Pediatr Cardiol. 2015; 37(1):37-43. DOI: 10.1007/s00246-015-1235-0. View

Chinnock R, Bailey L . Heart transplantation for congenital heart disease in the first year of life. Curr Cardiol Rev. 2012; 7(2):72-84. PMC: 3197092. DOI: 10.2174/157340311797484231. View

10.

Galantowicz M, Yates A . Improved outcomes with the comprehensive stage 2 procedure after an initial hybrid stage 1. J Thorac Cardiovasc Surg. 2015; 151(2):424-9. DOI: 10.1016/j.jtcvs.2015.10.023. View

11.

Lamour J, Kanter K, Naftel D, Chrisant M, Morrow W, Clemson B . The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol. 2009; 54(2):160-5. DOI: 10.1016/j.jacc.2009.04.020. View

12.

Rudd N, Frommelt M, Tweddell J, Hehir D, Mussatto K, Frontier K . Improving interstage survival after Norwood operation: outcomes from 10 years of home monitoring. J Thorac Cardiovasc Surg. 2014; 148(4):1540-7. DOI: 10.1016/j.jtcvs.2014.02.038. View

13.

Atz A, Travison T, Williams I, Pearson G, Laussen P, Mahle W . Prenatal diagnosis and risk factors for preoperative death in neonates with single right ventricle and systemic outflow obstruction: screening data from the Pediatric Heart Network Single Ventricle Reconstruction Trial(∗). J Thorac Cardiovasc Surg. 2010; 140(6):1245-50. PMC: 3143839. DOI: 10.1016/j.jtcvs.2010.05.022. View

14.

Dodge-Khatami A, Chancellor W, Gupta B, Seals S, Ebeid M, Batlivala S . Achieving Benchmark Results for Neonatal Palliation of Hypoplastic Left Heart Syndrome and Related Anomalies in an Emerging Program. World J Pediatr Congenit Heart Surg. 2015; 6(3):393-400. DOI: 10.1177/2150135115589605. View

15.

Mahle W, Ianucci G, Vincent R, Kanter K . Costs associated with ventricular assist device use in children. Ann Thorac Surg. 2008; 86(5):1592-7. DOI: 10.1016/j.athoracsur.2008.07.022. View

16.

Menon S, Keenan H, Weng H, Lambert L, Burch P, Edwards R . Outcome and resource utilization of infants born with hypoplastic left heart syndrome in the Intermountain West. Am J Cardiol. 2012; 110(5):720-7. DOI: 10.1016/j.amjcard.2012.04.050. View

17.

Bailey L, Nehlsen-Cannarella S, Doroshow R, Jacobson J, Martin R, Allard M . Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med. 1986; 315(15):949-51. DOI: 10.1056/NEJM198610093151507. View

18.

OBrien S, Clarke D, Jacobs J, Jacobs M, Lacour-Gayet F, Pizarro C . An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg. 2009; 138(5):1139-53. DOI: 10.1016/j.jtcvs.2009.03.071. View

19.

Bacha E, Daves S, Hardin J, Abdulla R, Anderson J, Kahana M . Single-ventricle palliation for high-risk neonates: the emergence of an alternative hybrid stage I strategy. J Thorac Cardiovasc Surg. 2006; 131(1):163-171.e2. DOI: 10.1016/j.jtcvs.2005.07.053. View

20.

Pizarro C, Derby C, Baffa J, Murdison K, Radtke W . Improving the outcome of high-risk neonates with hypoplastic left heart syndrome: hybrid procedure or conventional surgical palliation?. Eur J Cardiothorac Surg. 2008; 33(4):613-8. DOI: 10.1016/j.ejcts.2007.12.042. View